X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Orchid Chemicals with JUBILANT LIFE SCIENCES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs JUBILANT LIFE SCIENCES - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD JUBILANT LIFE SCIENCES ORCHID PHARMA LTD/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x -0.8 20.1 - View Chart
P/BV x 0.6 4.3 13.1% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 ORCHID PHARMA LTD   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
JUBILANT LIFE SCIENCES
Mar-14
ORCHID PHARMA LTD/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs194187 103.9%   
Low Rs3565 53.8%   
Sales per share (Unadj.) Rs276.5364.3 75.9%  
Earnings per share (Unadj.) Rs-79.26.8 -1,157.0%  
Cash flow per share (Unadj.) Rs-43.524.5 -177.4%  
Dividends per share (Unadj.) Rs03.00 0.0%  
Dividend yield (eoy) %02.4 0.0%  
Book value per share (Unadj.) Rs53.9164.9 32.7%  
Shares outstanding (eoy) m70.45159.28 44.2%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.40.3 119.8%   
Avg P/E ratio x-1.418.4 -7.9%  
P/CF ratio (eoy) x-2.65.1 -51.3%  
Price / Book Value ratio x2.10.8 277.9%  
Dividend payout %043.8 0.0%   
Avg Mkt Cap Rs m8,06720,061 40.2%   
No. of employees `0002.86.2 45.3%   
Total wages/salary Rs m2,52711,052 22.9%   
Avg. sales/employee Rs Th6,956.19,383.0 74.1%   
Avg. wages/employee Rs Th902.51,786.9 50.5%   
Avg. net profit/employee Rs Th-1,993.0176.3 -1,130.5%   
INCOME DATA
Net Sales Rs m19,47758,034 33.6%  
Other income Rs m407191 213.6%   
Total revenues Rs m19,88458,224 34.2%   
Gross profit Rs m1,1035,786 19.1%  
Depreciation Rs m2,5192,812 89.6%   
Interest Rs m5,2273,237 161.5%   
Profit before tax Rs m-6,236-72 8,649.4%   
Minority Interest Rs m20-286 -6.9%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5112,145 23.8%   
Tax Rs m-125696 -18.0%   
Profit after tax Rs m-5,5801,090 -511.8%  
Gross profit margin %5.710.0 56.8%  
Effective tax rate %2.0-965.9 -0.2%   
Net profit margin %-28.71.9 -1,524.9%  
BALANCE SHEET DATA
Current assets Rs m11,01429,280 37.6%   
Current liabilities Rs m32,06038,912 82.4%   
Net working cap to sales %-108.1-16.6 651.1%  
Current ratio x0.30.8 45.7%  
Inventory Days Days9584 112.4%  
Debtors Days Days3451 66.2%  
Net fixed assets Rs m29,44055,712 52.8%   
Share capital Rs m705155 456.0%   
"Free" reserves Rs m2,04320,968 9.7%   
Net worth Rs m3,80026,265 14.5%   
Long term debt Rs m9,01817,169 52.5%   
Total assets Rs m46,51088,606 52.5%  
Interest coverage x-0.21.0 -19.8%   
Debt to equity ratio x2.40.7 363.1%  
Sales to assets ratio x0.40.7 63.9%   
Return on assets %-0.84.9 -15.6%  
Return on equity %-146.94.2 -3,537.4%  
Return on capital %-3.711.6 -32.3%  
Exports to sales %37.937.8 100.2%   
Imports to sales %22.616.5 137.2%   
Exports (fob) Rs m7,37821,933 33.6%   
Imports (cif) Rs m4,4069,567 46.1%   
Fx inflow Rs m7,51322,004 34.1%   
Fx outflow Rs m5,64911,749 48.1%   
Net fx Rs m1,86510,255 18.2%   
CASH FLOW
From Operations Rs m1,6828,026 21.0%  
From Investments Rs m-9,860-1,744 565.3%  
From Financial Activity Rs m6,644-4,447 -149.4%  
Net Cashflow Rs m-1,5351,834 -83.7%  

Share Holding

Indian Promoters % 32.3 45.6 70.8%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 4.6 8.7 52.9%  
FIIs % 3.3 21.2 15.6%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 21.1 262.1%  
Shareholders   84,811 23,815 356.1%  
Pledged promoter(s) holding % 54.9 15.9 346.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   FRESENIUS KABI ONCO.  CIPLA  TORRENT PHARMA  SUVEN LIFE  WYETH LTD  

Compare ORCHID PHARMA LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Weak Finish to the Week Post Vishal Sikka's Exit as CEO of Infosys(Closing)

Share markets in India witnessed selling pressure, led by slump in shares of Infosys Ltd. after Vishal Sikka resigned as chief executive officer of the country's second-largest software services exporter.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Aug 18, 2017 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD - AUROBINDO PHARMA COMPARISON

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS